glp-1 agonist history of agonists glp 1 drugs Another milestone in the evolution GLP -1-based diabetes therapies Drug Market: the rapid – A schematic overview of GLP-1 – history of glp 1 agonists

Canadian Journal of Biochemistry, 57, 2337

For individuals living with Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), dysautonomia, and mast cell activation syndrome (MCAS), the search for answers often leads to the microscopic world of cellular metabolism

In the pursuit of optimal health, people are constantly searching for ways to feel better, look better, and perform better

GSH in Cancer Dual Roles in Carcinogenesis and Drug Resistance (PubMed, 2019) Elevated Tumour GSH as a Driver of Chemotherapy Resistance A comprehensive review published on PubMed examined GSHs dual roles in cancer biology chemopreventive in normal cells through carcinogen detoxification by GST, and pathogenic in tumour cells where elevated GSH levels are associated with tumour progression and increased resistance to chemotherapeutic drugs and radiotherapy

162 By trafficking cytotoxic agents into exocytic vesicles or blocking nuclear entry, LRP prevents engagement with nuclear DNA or enzymes